Drugs, Devices, and Diagnostics: New Challenges, Strategies, and Execution

CT Score

1500

#0 of 0 in QST HM

Difficulty

—/10

Workload

—h/wk

Median grade

—

from grade distribution

Would take again

—

n = 0 verified

Grade distribution

No distribution published for this course.

By professor: same course, different game

PROFESSORSCOREGRADEHRS/WKTERMS

Professor ratings →

Sections

No section data for this term yet.

In the tree

QST HM703, QST FE712 or FE722, QST MK723 or MK724, QST SI750 or SI751 - This course will examine issues and opportunities in life sciences focused on the pharmaceutical, biotechnology, medical devices sectors and the life sciences service industry supporting these sectors, through the eyes of the CEO. The course will investigate who manages these companies and what are the strategies that are used to build successful enterprises. Students will be introduced to individuals and institutions at every stage of the development cycle from idea generation and start-up fundraising to manufacturing, commercialization and global expansion. We will specifically look at key elements of strategy and the execution by examining companies, that have either succeeded or failed, by discussing the pros and cons of different approaches and teasing out the lessons one can derive from leaders in the field and case studies examining their approaches→QST HM 717→unlocks 0 courses

No mapped courses require this one yet. See on the map →

Study groups

0 active

🔒 Verified-only writes. You post as “sophomore, lecture section”: real enough to trust, anonymous enough to be honest.